PPP1R12A Copy Number Is Associated with Clinical Outcomes of Stage III CRC Receiving Oxaliplatin-Based Chemotherapy
Aim. To investigate the correlation between PPP1R12A gene copy number and clinical outcomes of oxaliplatin-based regimen in stage III colorectal cancer (CRC). Methods. A total of 139 paraffin-embedded tissue samples of stage III CRC patients who received oxaliplatin-based treatment after radical sur...
Saved in:
| Main Authors: | Chenbo Zhang, Ajian Li, Huaguang Li, Kangsheng Peng, Qing Wei, Moubin Lin, Zhanju Liu, Lu Yin, Jianwen Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2015-01-01
|
| Series: | Mediators of Inflammation |
| Online Access: | http://dx.doi.org/10.1155/2015/417184 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparison of PSOX (paclitaxel, oxaliplatin, S-1) and SOX (oxaliplatin, S-1) as postoperative adjuvant chemotherapy for stage II-III gastric cancer
by: Fei-Yu Wang, et al.
Published: (2025-03-01) -
Response of Capecitabine and Oxaliplatin Chemotherapy in Metastatic Colorectal Carcinoma
by: Asma Abdul Rashid, et al.
Published: (2025-01-01) -
6: Exon-level copy-number variants: The penultimate frontier in copy-number analysis?
by: Timothy Fee, et al.
Published: (2025-01-01) -
Intra-arterial hepatic chemotherapy in metastatic colorectal cancer: differences between oxaliplatin-naive versus oxaliplatin-pretreated patients
by: E. El Rawadi, et al.
Published: (2025-06-01) -
MICROARRAY ANALYSIS OF DNA COPY NUMBER ABERRATION IN BREAST TUMOR: CORRELATION WITH THE EFFICACY OF NEOADJUVANT CHEMOTHERAPY
by: N. V. Litviakov, et al.
Published: (2016-02-01)